UnitedHealth Stock on the Edge: 3 Threats You Need to Know

UnitedHealth (UNH) has stumbled before. Its stock has plunged more than 30% within a span of less than 2 months on 2 occasions in recent years, wiping out billions in market value, and erasing massive gains in a single correction. If history is any guide, UNH stock isn’t immune to sudden, sharp declines.

Specifically, we see these risks:

1. DOJ Criminal & Civil Investigation into MA Billing
2. Revenue Decline & Margin Compression from MA Exodus

To properly weigh these risks, it helps to unpack what has been driving UNH stock recently.

Risk 1: DOJ Criminal & Civil Investigation into MA Billing

• Details: Potential for billions in fines and penalties; Forced divestiture of Optum, or changes to the integrated model
• Segment Affected: UnitedHealthcare (Medicare Advantage) & Optum
• Potential Timeline: Next 12-18 Months
• Evidence: DOJ conducting criminal and civil probes into Medicare Advantage billing practices; Investigation confirmed to include Optum Rx billing and physician reimbursement (August 26, 2025)

Risk 2: Revenue Decline & Margin Compression from MA Exodus

• Details: First annual revenue decline in over a decade guided for 2026, Loss of over 2 million members from exiting unprofitable markets
• Segment Affected: UnitedHealthcare (Medicare & Medicaid)
• Potential Timeline: Next 2-3 Quarters
• Evidence: Guided for 2026 revenue to decline to $439 billion from $447.6 billion in 2025; Medical Care Ratio spiked to 89.1% in 2025, indicating severe margin pressure (April 15, 2026)

While keeping a track of developing risks is critical, UNH’s historical drawdown during market crises offers another lens to understand risk. It provides useful context that can help stay invested during high volatility market phases.

Is Risk Showing Up In Financials Yet?

• Revenue Growth: 9.7% LTM and 10.2% last 3-year average.
• Cash Generation: Nearly 4.4% free cash flow margin and 4.2% operating margin LTM.
• Valuation: UnitedHealth stock trades at a P/E multiple of 29.7

*LTM: Last Twelve Months

While the table above gives a good comparison vs S&P medians, understanding how UNH stands against industry peers is just as critical when evaluating its risk profile.

Protect Your Wealth Against Such Risks

Understanding a stock’s risks doesn’t protect your capital from sudden drawdowns. For investors focused on securing and growing long-term wealth, shifting from concentrated bets to a systematic portfolio offers a clear advantage. It diversifies away stock-specific risks, reduces volatility, and still provides upside exposure.

The Trefis High Quality (HQ) Portfolio, with 30 stocks, is engineered to capture high-probability market opportunities while managing downside risk. This approach has delivered over 105% in cumulative return since inception, outperforming the blended S&P 500, S&P mid-cap, and Russell 2000 benchmarks.

Footnotes

DOJ Criminal & Civil Investigation into MA Billing
[1] Cory Doctorow Named It ‘Enshittification’ I Mapped the 17 Federal Dockets in Q2 2026 That Prove It’s a Crime — Not a Trend. RealPage, Live Nation, Apple, Google, Meta, Amazon, UnitedHealth, and the $687 Billion in Pending Damages.
[2] UnitedHealth Group (UNH) Stock in 2026: America’s Healthcare Giant Under Siege, and What Traders Need to Know – Phemex
Revenue Decline & Margin Compression from MA Exodus
[3] The Giant Realigns: A 2026 Deep Dive into UnitedHealth Group (UNH)
[5] UnitedHealth: After The Collapse (NYSE:UNH) | Seeking Alpha